Tag Archives: Neurological Disease

Deep Brain Stimulation for Improving Symptoms in Alzheimer’s Disease (BBC News)

Posted on January 30, 2018 by Dementia and Elderly Care News

Summary A brief BBC News item explores the potential of deep brain stimulation (DBS) therapy for improving wellbeing and cognitive function in patients with Alzheimer’s Disease and other forms of dementia. “Although we are not talking about treating the Alzheimer’s … Continue reading →

Posted in BBC News, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Quick Insights, Universal Interest | Tagged Alzheimer's Disease, Andres Lozano (Neurosurgeon), Brain Imaging, Canada, Deep Brain Stimulation, Deep Brain Stimulation (DBS), Deep Brain Stimulation for the Treatment of Alzheimer Disease, Deep Brain Stimulation for the Treatment of Dementia, Deep Brain Stimulation of Nucleus Basalis of Meynert (NBM DBS), Dr Carol Routledge: Alzheimer's Research UK, LaVonne Moore, Neurodegeneration, Neurodegenerative Diseases, Neurological Disease, Nucleus Basalis of Meynert, Nucleus Basalis of Meynert (NBM), Ohio State University Wexner Medical Center, Parkinson’s Dementia, Parkinson’s Disease Dementia, Treatment of Alzheimer's Disease, United States, USA, Wexner Medical Center: Ohio State University | Leave a comment

A Further Set-Back for Progress in Dementia Drug Development? (BBC News)

Posted on January 11, 2018 by Dementia and Elderly Care News

Summary Drug company Pfizer is to cease activity in its neuroscience drug discovery programmes, which will impact on ongoing research into drugs for Alzheimer’s Disease and Parkinson’s Disease. Paradoxically the company does promise plans to create a new fund dedicated … Continue reading →

Posted in BBC News, For Researchers (mostly), In the News, International, Management of Condition, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged Big Pharma, Dementia Research, Dementia Research Funding, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Drug Discovery Programmes, Drug Identification, Drug Trials Failure Rate, Drug-Development Pipeline, Global Context, Global Outlook, International Organisations, International Programmes, Neurological Conditions, Neurological Disease, Neurological Disorders, Neuroscience Drug Discovery Programmes (Pfizer), Neuroscience Research, Pfizer, Pfizer Inc., Pharmaceutical Industry, Research and Development, Research and Innovation, Research Commitment, Research Funding | Leave a comment

Parkinson’s Disease in Adults: Updated Guidance (NICE / BBC News / NHS Choices / Lancet)

Posted on August 4, 2017 by Dementia and Elderly Care News

Summary The National Institute for Health and Care Excellence recently released an updated guideline on the diagnosis and management of Parkinson’s Disease in patients aged over 18 years. This guidance updates and replaces their earlier “NG35 – Parkinson’s disease in … Continue reading →

Posted in BBC News, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, International, Management of Condition, National, NHS Digital (Previously NHS Choices), NICE Guidelines, Non-Pharmacological Treatments, Parkinson's Disease, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, UK | Tagged : National Institute on Aging (USA), Amantadine, BBC Health News, Behind the Headlines, Biomedical Research Centres (NIHR), Comprehensive Clinical Trials Unit: University College London, COMT Inhibitors, Deep Brain Stimulation (DBS), Diagnosing Parkinson's Disease, Dopamine Agonists, Dr Brian Fiske: The Michael J Fox Foundation for Parkinson's Research, Exenatide, Exenatide as Potential Treatment for Patients with Parkinson's Disease, GLP-1 Agonists for Parkinson's Disease, Impulse Control Disorders, Impulse Control Disorders (ICDs), Impulsive-Compulsive Disorders, Impulsivity, Information and Support, Institute of Nuclear Medicine: University College London Hospitals NHS Trust, Intramural Research Program: National Institute on Aging, Leonard Wolfson Experimental Neuroscience Centre, Levodopa, Levodopa–Carbidopa Intestinal Gel, MAO‑B Inhibitors, Michael J Fox Foundation, Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS), National Hospital for Neurology and Neurosurgery, National Hospital for Neurology and Neurosurgery: UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery: University College London Hospitals NHS Foundation Trust, National Institute for Health and Care Excellence (NICE), National Institute for Health Research Biomedical Research Centres, National Institute for Health Research UCL Hospitals Biomedical Research Centre, National Institutes of Health (Baltimore), Neurological Disease, Neurological Disorders, NHNN: National Hospital for Neurology and Neurosurgery, NIHR Biomedical Research Centres, Non-Pharmacological Management of Symptoms, Occupational Therapy, Off-Label Drug Repurposing Trials, Palliative Care, Parkinson's, Parkinson's Disease in Over 20s (Updated and Replaced), Parkinson’s Disease, Parkinson’s Disease Diagnosis, Parkinson’s Disease In Adults: NICE Guidance (NG71), Parkinson’s Disease in Adults: Updated Guidance (NICE 2017), Parkinson’s Pathway, Parkinsonian Symptoms, Pharmacological Management of Motor Symptoms, Pharmacological Management of Non-Motor Symptoms, Potential Repurposing of Drugs to Slow Progression of Parkinson’s Disease, Professor David Dexter: Parkinson's UK, Repurposing GLP-1 Agonists, Repurposing of Drugs, Sobell Department of Motor Neuroscience (UCL), Speech and Language Therapy (SALT), Translational Gerontology Branch: National Institute on Aging, Type 2 Diabetes Drug: Exenatide, University College London (UCL), University College London Hospitals NHS Trust, University College London Institute of Neurology, University College London Institute of Neurology and the National Hospital for Neurology and Neurosurgery, US National Institute of Aging | Leave a comment

Perioperative Care of Patients With Neurological Conditions (Health Service Insights)

Posted on June 30, 2017 by Dementia and Elderly Care News

Summary A US review covers the peri-operative care of patients with neurological conditions. It examines, in particular, aspects of the preoperative, intraoperative, and postoperative care for persons with conditions including delirium, stroke, epilepsy, myasthenia gravis, and Parkinson Disease. Full Text … Continue reading →

Posted in Acute Hospitals, Delirium, Diagnosis, For Nurses and Therapists (mostly), International, Management of Condition, Non-Pharmacological Treatments, Parkinson's Disease, Person-Centred Care, Pharmacological Treatments, Quick Insights, Stroke | Tagged Bronx-Lebanon Hospital Center (New York), Carotid Artery Disease and Stroke During Coronary Artery Bypass, Contraindications for Thrombolytic Therapy, Department of Medicine: Bronx-Lebanon Hospital Center, Department of Medicine: Icahn School of Medicine at Mount Sinai, Epilepsy, Health Service Insights (Journal), Icahn School of Medicine at Mount Sinai (New York), Intraoperative Care, Medications Which May Worsen Myasthenia Gravis, Myasthenia Gravis, Neurological Conditions, Neurological Disease, Neurological Disorders, Peri-Operative Care of the Elderly, Perioperative Care, Perioperative Care of Patients With Neurological Conditions, Perioperative Stroke, Postoperative Care, Preoperative Care, USA | Leave a comment

Progression of Neurological Diseases Presaged By Hidden Alterations in Artistic Style? (BBC News / Neuropsychology)

Posted on December 29, 2016 by Dementia and Elderly Care News

Summary Psychological researchers performed detailed mathematical analysis (“fractal analysis”) of barely perceptible changes to the brushstrokes used by artists, some of whom later developed neurological diseases. Analysis of hidden patterns of change in the fractal dimension of paintings reveals that … Continue reading →

Posted in BBC News, For Researchers (mostly), In the News, International, Quick Insights, UK, Universal Interest | Tagged Alterations to Artistic Style, and Wear Valleys NHS Trust, Artworks, BBC Health News, Department of Computer Science: Maynooth University, Department of Psychology: University of Liverpool, Disease Progression, Fine Art, Fine Motor Control, Fractal Analysis of Artistic Brushstrokes, Fractal Analysis of Neurological Changes (In Artists), Fractal Analysis of Paintings, Ireland, Maynooth University, Neurological Conditions, Neurological Disease, Neurological Disorders, Neuropsychology (Journal), Progression of Neurological Diseases, Pyschology of Art, Symptoms and Progression of Dementia, Tees Esk, University of Liverpool, Variations in Motor Control | Leave a comment

Fourth Annual Deep Brain Stimulation (DBS) Think Tank (Frontiers in Integrative Neuroscience / International Journal of Neuroscience)

Posted on December 15, 2016 by Dementia and Elderly Care News

Summary An annual round-up of developments in the field of Deep Brain Stimulation (DBS). (x3). Full Text Link Reference Deeb, W. Giordano, JJ. [and] Rossi, PJ. [et al] (2016). Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: a … Continue reading →

Early Indications Suggest Zika Virus Might Damage Adult Brains Resulting in Long-Term Neurological Conditions (NHS Choices / Cell Stem Cell)

Posted on August 20, 2016 by Dementia and Elderly Care News

Summary The Zika virus has been linked with microcephaly in human babies, and has also – more tentatively – been linked to Guillain-Barre Syndrome (GBS), but until now was not thought likely to affect the adult population beyond minor short-term … Continue reading →

Posted in Animal Studies, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest | Tagged Aging and Stem Cell Regeneration: Sanford Burnham Prebys Discovery Institute, Apoptosis and Reduced Cellular Proliferation, Apoptotic Neural Cell Death, Behind the Headlines, California Institute of Regenerative Medicine, Caribbean Countries, Cell Stem Cell (Journal), Central America, Central Nervous System Abnormalities, CNS Infections, Del. E. Webb Center for Neuroscience: Sanford Burnham Prebys Discovery Institute, Dementia Risk Factors, Dengue Virus, Department of Neurosciences: University of California, Division of Inflammation Biology: La Jolla Institute for Allergy and Immunology, Environmental Risk Factors, Flaviviruses, Genetically Engineered Mice, Guillain-Barré Syndrome, Guillain-Barre Syndrome (GBS), Hippocampus, Hippocampus-Based Cognitive Processes, Howard Hughes Medical Institute, Howard Hughes Medical Institute: Rockefeller University, Infection, Infection and Infectious Diseases, La Jolla Institute for Allergy and Immunology, La Jolla Institute for Genomic Medicine, Laboratory for Pediatric Brain Diseases: Howard Hughes Medical Institute, Long Term Neurological Conditions, Microcephaly, National Institutes of Health (NIH), National Institutes of Health (US), Neural Progenitor Cells (NPCs), Neurobiology of ZIKV and Potential Neuropsychiatric Manifestations, Neurogenesis, Neurological Complications, Neurological Conditions, Neurological Disease, Neurological Disorders, Pathogenesis, Rady Children’s Institute for Genomic Medicine: University of California, Risk Factors, Risks to Immunocompromised Adults, Rockefeller University, Sanford Burnham Prebys Discovery Institute, Simons Foundation of Autism Research Initiative, South America, Subgranular Zone (SGZ) of Hippocampus, Subventricular Zone (SVZ) of Anterior Forebrain, Systemic ZIKV Can Infect Neural Progenitor Cells in the Adult Brain, The Americas, TKO Mice (Mice With Immune Cells Knocked Out), United States, University of California, USA, World Health Organization (WHO): Zika Public Health Emergency of International Concern, Zika Fever, Zika Infection Leading to Neural Cell Death and Reduced Cell Division, Zika Virus, Zika Virus (ZIKV) Infection, Zika Virus Epidemiology and Recent Epidemics, Zika Virus Infection: Public Health Issues, Zika Virus Outbreaks in the Americas, ZIKV Pandemic | Leave a comment

New Models of Care in Community Neurology (Neurological Alliance / Thames Valley Strategic Clinical Network)

Posted on June 26, 2016 by Dementia and Elderly Care News

Summary Thames Valley Strategic Clinical Network has published an extensive “Transforming Community Neurology: What Commissioners Need to Know” briefing, on improving community services for people with long-term neurological conditions. This report comprises three parts: Part A: Transformation Guide. Part B: … Continue reading →

Posted in Commissioning, Community Care, Depression, End of Life Care, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Local Interest, Management of Condition, Mental Health, National, NHS, Non-Pharmacological Treatments, Parkinson's Disease, Patient Care Pathway, Person-Centred Care, Physiotherapy, Quick Insights, Standards, Telecare, Telehealth, UK, Universal Interest | Tagged 3-Tier Framework of Care Stratification, 5YFV: NHS Five Year Forward View, Access to Care, Access to Community Rehabilitation and Support Services, Admission Avoidance, Aggregated Data, Arlene Wilkie: Chief Executive of Neurological Alliance, Barnet Community Neuro Conditions Management Team, Benchmarking, Benchmarking Tools, Benefits of Community Models of Care, Block Contracts and Payments-by-Results (PbR), Capacity Payments, Capitated Payments, Capitation Models, Care Closer to Home, Care Co-ordination, Care Planning, Care Planning (Community), care.data, Carer Support Services, Carer’s Surveys, Carers Alert Thermometer, Carers and Families, Case Study Report on Sandwell, Changing Lives Reintegration Service (Tyneside), Changing Lives: Community Integration Service, Charity and Patient Organisation User Groups, Child and Adolescent Mental Health Services Payment Project, Clinical Commissioning Groups (CCGs), CNCMT: Community Neuro Conditions Management Team, Colchester Community Neuro-Rehabilitation Team, Colchester Neuro Rehab Team, Colchester Neuro-Rehabilitation Team, Commissioning for Parity of Esteem, Community Care Models, Community Comorbidity Management, Community Information Data Set (CIDS), Community Neuro Conditions Management Team, Community Neurology Conference (June 2016), Community Neurology Project, Community Neurology Services, Community Neurology Services: What Commissioners Need to Know, Community Outreach, Community Outreach Rehabilitation, Community Patient Currencies, Community Rehabilitation and Support, Community Service Funding Arrangements, Community-Based Care, Community-Based Services, Community-Based Support, Core Team Competencies, Cost(s) of Neurological Conditions, Cumbria Headache Forum, Cumbria Partnership NHS Foundation Trust, Currencies for Healthcare Services, Data Aggregation, Data Linked by NHS Number, Data Linking, Dawn Langdon: Royal Holloway University of London, Dementia Long-Term Services, Dr Rishi Mannan: NHS Windsor Ascot and Maidenhead CCG, Dudley Joint Commissioning Strategy for Long Term Neurological Conditions, E-Health, Epilepsy Action’s Commissioning Toolkit, Equipment and Accommodation, Factors Affecting Costs of Neurological Care, Failure to Meet Patients’ Needs, Features of New Care Models, Feedback Mechanisms, Five Year Forward View (NHS England), Funding Flows, Gold Standards Framework, Gold Standards Framework (GSF), GP Clinical Systems, GP Patient Survey, Health Inequalities, Hospice-Based Educational Support (To Patients), Identifying Patients’ Needs and Priorities, Ignoring Mental Health, Improving Access to Psychological Therapies (IAPT), Inappropriate Hospital Admissions, Independence, Integrated Community Neurology Care Pathways, Integrated Multi-Agency Care, Integrating Care Pathways, Integration of Physical and Mental Health, Interaction between Physical and Mental Health, Interface Between Primary and Secondary Care, International Consortium for Health Outcomes Measurement (ICHOM), Jill Kings: Clinical Director of Neural Pathways, Joanne Ross: Assistant Director of Neurological Services at Sue Ryder, Levels of Intervention, Living With Neurological Conditions, Local Variations, LOHO Project, Long Term Neurological Conditions, Long-Term Care (LTC), Long-Term Care and Support, Long-Term Conditions, Long-Term Conditions and Dementia, Longitudinal Care-Cycle Evaluation (UK-ROC), Lorn and Oban Healthy Options (LOHO) Project, Maintaining Independence, Managing Cognitive Difficulties in Community Neurology, Managing Emotional Distress in Community Neurology, Mark Stone: NHS Patient Partner, Mental Health and Well-Being in Community Neurology Services, Mental Health Currencies, Mental Well-Being, Mental Wellbeing, Merging the Interfaces of Primary and Secondary Care, Multi-Agency Collaboration, Multi-Agency Integration, Multi-Agency Working, Multispeciality Community Providers (MCPs), Multispecialty Community Providers (MCPs), National Service Framework for Long Term ConditionsNational Service Framework for Long Term Conditions, Needs of Carers, Needs-Based Services, Neural Pathways (UK), Neuro Case Management Service (CMS), Neurological Alliance, Neurological Alliance Regional Groups, Neurological Conditions, Neurological Datasets, Neurological Disease, Neurological Disorders, Neurological Problems, Neurology Care Pathways, Neurology Datasets and Benchmarking, Neurology Intelligence Network (NIN) Data, Neurology-Specific Measures, New Models of Care, New Models of Care in Community Neurology, NHS East Midlands Strategic Clinical Network, NHS England’s Five Year Forward View, NHS Five Year Forward View (5YFV), NHS Homerton City and Hackney CCG, NHS Homerton City and Hackney CCG: Parkinson’s Pathway, NHS Nottingham City CCG, NHS Outcomes Framework, NHS RightCare, NHS RightCare Commissioning for Value Packs for CCGs, NHS Windsor Ascot and Maidenhead CCG, NIHR CLAHRC Wessex, NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Wessex, Northumberland Tyne and Wear NHS Foundation Trust, Nottingham CityCare, Nottingham CityCare Community Neurology Team, Optimising Mental Well Being, Overarching Measures, Oxfordshire Neurological Alliance, Palliative Care, Parity of Esteem, Parkinson’s Pathway, Patient Experience Surveys, Patient Groups and Forums, Patient Reported Outcome Measures (PROMs), Patients Technology and Data at the Heart of Transformation, Payment Mechanisms, Permanent Feedback Channels, Personal Health Budgets (PHBs), Place-Based Planning, Poor Coordination, Practical and Emotional Support, Public Accounts Committee (PAC), Redesigning Services, Reducing Hospital Length of Stay, Reducing Unplanned Hospital Admissions, Reference Reports, Risk Stratification, Royal Free Hospital: Neuro Rehabilitation Centre, Sarah Marsh: LTC Clinical Policy and Strategy Unit at NHS England, Secondary Uses Service (SUS) Data, Self-Care, Self-Management, Sentinel Stroke National Audit Programme (SSNAP), Service Redesign, Services Reducing Use of Hospitals, Sheffield Health and Social Care Foundation Trust, Sheffield Neuro Case Management Service, Short and Long-Term Neuro-Rehabilitation Services, Socio-Economic Burden of Long-Term Neurological Conditions, Southampton and Royal Holloway London Universities, St Clare Hospice in West Essex, Staying Independent, Stephen Williams: Community Neurology Project, Stratification of Care (Levels 1-3), Sue Ryder, Sunderland and Gateshead CABIS, Sunderland and Gateshead Community Acquired Brain Injury Service (CABIS), Supporting Family and Carers, Supporting Self-Care, Sustainability, Sustainability and Transformation Plan (STP), Tees Valley Durham and North Yorkshire (TVDNY) Neurological Alliance, Thames Valley SCN, Thames Valley Strategic Clinical Network, Thames Valley Strategic Clinical Network (SCN), Third Sector Organisations, Three-Tier Framework of Care Stratification, Tier 1: Care Coordination, Tier 2: Needs Led Intervention, Tier 3: Self Care, Transforming Community Neurology, TVDNY Neurological Alliance, UK Rehabilitation Outcomes Collaborative, Unacceptable Variations, Unpaid Carers, Vanguard Sites, Variations in Quality of Care, Variations in Service, Variety of Neurological Conditions, Vertical Integration (of Primary and Secondary Care), Vocational Rehabilitation, West Essex Neuro Community Team, West Essex Neurological Community Team, Windsor Ascot and Maidenhead Clinical Commissioning Group, Year of Care Model, Zameel Cader: Clinical Director for Mental Health Neurology and Dementia at Thames Valley Strategic Clinical Network | Leave a comment

Non-Alzheimer’s Dementias: Three Reviews (Lancet)

Posted on October 24, 2015 by Dementia and Elderly Care News

Summary The Lancet has published a series of three up-to-date reviews concerning non-Alzheimer’s dementia. Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access). Reference Dementia – not all about Alzheimer’s. [Editorial]. … Continue reading →

Local Variations in Neurology Outpatient Services in England (PHE)

Posted on August 30, 2015 by Dementia and Elderly Care News

Summary The Public Health England (PHE) Neurology Intelligence Network (NIN) has published a statistical briefing concerning neurological outpatient activity in England. This concentrates particularly on local CCG services. Quality improvements may be achievable by examining variations in local service provision, … Continue reading →

Posted in Commissioning, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Local Interest, Management of Condition, National, NHS, Public Health England, Quick Insights, Royal College of Physicians, Standards, Statistics, UK, Universal Interest | Tagged Airedale Wharfedale and Craven CCG, Ashford CCG, Association of British Neurologists, Aylesbury Vale CCG, Barking & Dagenham CCG, Barnet CCG, Barnsley CCG, Basildon and Brentwood CCG, Bassetlaw CCG, Bath and North East Somerset CCG, Bedfordshire CCG, Bexley CCG, Birmingham CrossCity CCG, Birmingham South and Central CCG, Blackburn with Darwen CCG, Blackpool CCG, Bolton CCG, Bracknell and Ascot CCG, Bradford City CCG, Bradford Districts CCG, Brent CCG, Brighton & Hove CCG, Bristol CCG, Bromley CCG, Bury CCG, Calderdale CCG, Cambridgeshire and Peterborough CCG, Camden CCG, Cannock Chase CCG, Canterbury and Coastal CCG, Castle Point and Rochford CCG, Central London (Westminster) CCG, Central Manchester CCG, Chiltern CCG, Chorley and South Ribble CCG, City and Hackney CCG, Clinical Commissioning Groups (CCGs), Coastal West Sussex CCG, Consultant Focussed Services, Consultant Neurology Outpatient Appointments 2012 to 2013, Corby CCG, Coventry and Rugby CCG, Crawley CCG, Croydon CCG, Cumbria CCG, Darlington CCG, Dartford Gravesham and Swanley CCG, Doncaster CCG, Dorset CCG, Dudley CCG, Durham Dales Easington and Sedgefield CCG, Ealing CCG, East and North Hertfordshire CCG, East Lancashire CCG, East Leicestershire and Rutland CCG, East Midlands, East of England, East Riding of Yorkshire CCG, East Staffordshire CCG, East Surrey CCG, Eastbourne Hailsham and Seaford CCG, Eastern Cheshire CCG, Enfield CCG, Erewash CCG, Fareham and Gosport CCG, Fylde & Wyre CCG, Gateshead CCG, Geographical Variations, Gloucestershire CCG, Great Yarmouth & Waveney CCG, Greater Huddersfield CCG, Greater Preston CCG, Greenwich CCG, Guildford and Waverley CCG, Halton CCG, Hambleton Richmondshire and Whitby CCG, Hammersmith and Fulham CCG, Hardwick CCG, Haringey CCG, Harrogate and Rural District CCG, Harrow CCG, Hartlepool and Stockton-on-Tees CCG, Hastings & Rother CCG, Havering CCG, Herefordshire CCG, Herts Valleys CCG, Heywood Middleton & Rochdale CCG, High Weald Lewes Havens CCG, Hillingdon CCG, Horsham and Mid Sussex CCG, Hounslow CCG, Hull CCG, Ipswich and East Suffolk CCG, Isle of Wight CCG, Islington CCG, John Newton: Chief Knowledge Officer at Public Health England, Kernow CCG, Kingston CCG, Knowsley CCG, Lambeth CCG, Lancashire North CCG, Leeds North CCG, Leeds South and East CCG, Leeds West CCG, Leicester City CCG, Lewisham CCG, Lincolnshire East CCG, Lincolnshire West CCG, Liverpool CCG, Local Adult Neurology Services for Next Decade Report (2011), Local Commissioning, Local Commissioning Groups, Local Neurology Services: Outpatient Analysis, Local Variations, Local Variations in Neurology Outpatient Services, Luton CCG, Mansfield & Ashfield CCG, Medway CCG, Mental Health Dementia and Neurology Intelligence Network (MHDNIN), Mental Health Dementia and Neurology Intelligence Network (MHIN), Mental Health Dementia and Neurology Intelligence Networks, Mental Health Dementia and Neurology ProfilesMental Health Dementia and Neurology Profiles, Mental Health Dementia and Neuroscience (SCN), Merton CCG, Method for Variation Approach, MHDNIN: Mental Health Dementia and Neurology Intelligence Network, Mid Essex CCG, Milton Keynes CCG, National Mental Health Dementia and Neurology Intelligence Networks, Nene CCG, Neurological Alliance, Neurological Datasets, Neurological Disease, Neurological Disorders, Neurology Intelligence Network (NIN), Neurology Outpatient Analysis, Neurology Outpatient Appointments 2012 to 2013 Data, Neurology Outpatient Services, Neurology Outpatient Services in England, Neurology Profiles, Newark & Sherwood CCG, Newbury and District CCG, Newcastle North and East CCG, Newcastle West CCG, Newham CCG, NHS South Lincolnshire CCG, NHS Wyre Forest CCG, Nondegenerative Neurological Diseases (NNDs), North & West Reading CCG, North Derbyshire CCG, North Durham CCG, North East Essex CCG, North East Hampshire and Farnham CCG, North East Lincolnshire CCG, North East West Devon CCG, North Hampshire CCG, North Kirklees CCG, North Lincolnshire CCG, North Manchester CCG, North Norfolk CCG, North Somerset CCG, North Staffordshire CCG, North Tyneside CCG, North West of England, North West Surrey CCG, Northumberland CCG, Norwich CCG, Nottingham City CCG, Nottingham North & East CCG, Nottingham West CCG, Oldham CCG, Oliver Sacks: Author of the book "Awakenings", Oxfordshire CCG, PHE Neurology Intelligence Network (NIN), PHE: Public Health England, Portsmouth CCG, Prevalence of Neurological Conditions, Public Health England (PHE), Public Health England (PHE) Neurology Intelligence Network (NIN), Quality Improvement, Redbridge CCG, Redditch and Bromsgrove CCG, Reducing Variation, Richmond CCG, Rotherham CCG, Royal College of Physicians (RCP), Rushcliffe CCG, Salford CCG, Sandwell and West Birmingham CCG, Scarborough and Ryedale CCG, Sheffield CCG, Shropshire CCG, Slough CCG, Solihull CCG, Somerset CCG, South Cheshire CCG, South Devon and Torbay CCG, South East Coast, South East Staffs and Seisdon Peninsular CCG, South Eastern Hampshire CCG, South Gloucestershire CCG, South Kent Coast CCG, South Lincolnshire CCG, South Manchester CCG, South Norfolk CCG, South Reading CCG, South Sefton CCG, South Tees CCG, South Tyneside CCG, South Warwickshire CCG, South West, South West Lincolnshire CCG, South Worcestershire CCG, Southampton CCG, Southend CCG, Southern Derbyshire CCG, Southport and Formby CCG, Southwark CCG, St Helens CCG, Stafford and Surrounds CCG, Stockport CCG, Stoke on Trent CCG, Strategic Clinical Networks (SCNs), Sunderland CCG, Surrey Downs CCG, Surrey Heath CCG, Sutton CCG, Swale CCG, Swindon CCG, Tameside and Glossop CCG, Telford & Wrekin CCG, Thames Valley, Thanet CCG, Thurrock CCG, Tower Hamlets CCG, Trafford CCG, Unacceptable Variations, Unwarranted Variations, Vale of York CCG, Vale Royal CCG, Variation in Commissioning, Variation in Use of Neurology Diagnostic Services, Variations in Care, Variations in Quality of Care, Variations in Spending, Wakefield CCG, Walsall CCG, Waltham Forest CCG, Wandsworth CCG, Warrington CCG, Warwickshire North CCG, Wessex, West Cheshire CCG, West Essex CCG, West Hampshire CCG, West Kent CCG, West Lancashire CCG, West Leicestershire CCG, West London (K&C & QPP) CCG, West Midlands, West Norfolk CCG, West Suffolk CCG, Wigan Borough CCG, Wiltshire CCG, Windsor Ascot and Maidenhead CCG, Wirral CCG, Wokingham CCG, Wolverhampton CCG, YHPHO | Leave a comment

Tag Archives: Neurological Disease

Deep Brain Stimulation for Improving Symptoms in Alzheimer’s Disease (BBC News)

A Further Set-Back for Progress in Dementia Drug Development? (BBC News)

Parkinson’s Disease in Adults: Updated Guidance (NICE / BBC News / NHS Choices / Lancet)

Perioperative Care of Patients With Neurological Conditions (Health Service Insights)

Progression of Neurological Diseases Presaged By Hidden Alterations in Artistic Style? (BBC News / Neuropsychology)

Fourth Annual Deep Brain Stimulation (DBS) Think Tank (Frontiers in Integrative Neuroscience / International Journal of Neuroscience)

Early Indications Suggest Zika Virus Might Damage Adult Brains Resulting in Long-Term Neurological Conditions (NHS Choices / Cell Stem Cell)

Local Variations in Neurology Outpatient Services in England (PHE)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites